Fungal distribution and drug resistance of pulmonary interstitial fibrosis accompanied by pulmonary fungal infection
Mai Jia
Wang Jing
Abstract：Objective To investigate the fungal distribution and drug resistance of pulmonary interstitial fibrosis accompanied by pulmonary fungal infection.Methods 45 cases of pulmonary interstitial fibrosis accompanied by pulmonary fungal infection treated in the First Affiliated Hospital of ZhengZhou University were selected.The fungal distribution and drug resistance was analyzed. Results There were 24 strains of Candida albicans,accounted for 53.33%;10 strains of Candida glabrata,accounted for 22.22%;6 strains,accounted for 13.33%;2 strains of Candida krusei, accounted for 4.44%.Fluconazole,itraconazole,amphotericin B,Fushita Yasu,5 -fluorocytosine resistance rates were 17.78%,26.67%,8.89%,0.00%,0.00%respectively.Conclusion Candida albicans was the most common cause of pul-monary interstitial fibrosis accompanied by pulmonary fungal infection with strong resistance to itraconazole.The diagnosis and ra-tional use of drugs for pulmonary interstitial fibrosis accompanied by pulmonary fungal infection should be paid more attentions.
Keywords：pulmonary interstitial fibrosisfungal infectionfungal distributiondrug resistance
Publication Date：2015-01-01
Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)
Pages：3( 20-22 )